Tegaserod for the treatment of irritable bowel syndrome and chronic constipation-Reference-Cited by-同舟云学术

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

Published:2007-10-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Evans Beti W¹,Clark Wendy K²,Moore David J³,Whorwell Peter J⁴

Affiliation:

1. University of Hertfordshire; School of Pharmacy; College Lane Campus Hatfield UK AL10 9AB

2. Keele University; Medicines Management; Department of Medicines Management Keele University Newcastle-under-Lyme Staffordshire UK ST5 5BG

3. University of Birmingham; Aggressive Research Intelligence Facility; Aggressive Research Intelligence Facility Department of Public Health & Epidemiology University of Birmingham West Midlands UK B15 2TT

4. Wythenshawe Hospital; Medical Academic Department; First floor, Education and Research Centre Southmoor Road Manchester UK M23 9LT

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD003960.pub3/fullpdf

Reference51 articles.

1. Novartis Pharmaceuticals Corporation East Hanover New Jersey Zelmac (tegaserod) Advisory Committee Briefing Document http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3627b1a.pdf 1 93

2. Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms;Fidelholtz;Am J Gastroenterol,2002

3. Rawls J Lefkowitz M Shi Y Zack A Dunger-Baldauf C Ruegg PC Gut 2000 A217

4. Hamling J Bang CJ Tarpila S Stewart W Rueegg PC Digestion 1998 735 (abstract B5324)

5. Novartis Pharmaceuticals Corporation East Hanover New Jersey Zelmac (tegaserod) Advisory Committee Briefing Document http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3627b1a.pdf 1 93

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Organic Compounds Mimicking the Effector Domain of Myristoylated Alanine-Rich C-Kinase Substrate Stimulate Female-Specific Neurite Outgrowth;International Journal of Molecular Sciences;2023-09-19

2. Serotonergic Control of Gastrointestinal Development, Motility, and Inflammation;Comprehensive Physiology;2023-06-26

3. Chronic Small Bowel Dysfunction;Intestinal Failure;2023

4. New multimodal intervention to reduce irritable bowel syndrome (IBS) severity symptoms—Pilot study with a 12 month follow-up;PLOS ONE;2022-11-21

5. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?;World Journal of Gastroenterology;2022-03-28